Cite
HARVARD Citation
Onali, S. et al. (2022). An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors. American journal of gastroenterology. pp. 1279-1287. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Onali, S. et al. (2022). An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors. American journal of gastroenterology. pp. 1279-1287. [Online].